These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36128779)

  • 21. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient Global Cerebral Hypoperfusion as a Characteristic Cerebral Hemodynamic Pattern in the Acute Stage after Combined Revascularization Surgery for Pediatric Moyamoya Disease: N-Isopropyl-P-[123I] Iodoamphetamine Single-Photon Emission Computed Tomography Study.
    Kanoke A; Fujimura M; Tashiro R; Ozaki D; Tominaga T
    Cerebrovasc Dis; 2022; 51(4):453-460. PubMed ID: 34933301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Ischemic Risk Using Blood Oxygen Level-Dependent MRI in Children with Moyamoya.
    Dlamini N; Slim M; Kirkham F; Shroff M; Dirks P; Moharir M; MacGregor D; Robertson A; deVeber G; Logan W
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):160-166. PubMed ID: 31806596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of Revascularization in Ischemic Moyamoya Disease: Association of Early Versus Delayed Surgery with Perioperative and Long-Term Outcomes.
    Xu R; Xie ME; Khalifeh J; Feghali J; Yang W; Kim J; Liew J; Tamargo RJ; Huang J
    World Neurosurg; 2022 Oct; 166():e721-e730. PubMed ID: 35931338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial spin labeling as an ancillary assessment to postoperative conventional angiogram in pediatric moyamoya disease.
    Lang SS; Tucker AM; Schreiber C; Storm PB; Liu H; Li Y; Ichord R; Beslow LA; Sedora-Roman NI; Cox M; Nasser H; Vossough A; Fisher MJ; Kilbaugh TJ; Huh JW
    J Neurosurg Pediatr; 2022 Jan; 29(1):40-47. PubMed ID: 34598159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moyamoya disease in children.
    Ibrahimi DM; Tamargo RJ; Ahn ES
    Childs Nerv Syst; 2010 Oct; 26(10):1297-308. PubMed ID: 20607248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Imaging risk factors for postoperative cerebral infarction in adults with ischemic Moyamoya disease].
    Yu TF; Ye X; Zeng C; Chen XL; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(15):1310-1315. PubMed ID: 38637167
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Moyamoya Biomarkers: Narrowing the Knowledge Gap.
    Lehman LL; Kaseka ML; Stout J; See AP; Pabst L; Sun LR; Hassanein SA; Waak M; Vossough A; Smith ER; Dlamini N
    Semin Pediatr Neurol; 2022 Oct; 43():101002. PubMed ID: 36344019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient ischemic attack after indirect revascularization surgery for pediatric patients with moyamoya disease: A retrospective study of intraoperative blood pressure.
    Zhu B; He L
    Anaesth Crit Care Pain Med; 2023 Feb; 42(1):101168. PubMed ID: 36309164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Ischemic Stroke After Revascularization Surgery in Patients with Moyamoya Disease: An Age-Stratified Comparative Meta-Analysis.
    Pettersson SD; Olofsson HKL; Ali S; Szarek D; Miękisiak G; Ogilvy CS
    World Neurosurg; 2023 May; 173():146-157.e14. PubMed ID: 36716854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.
    Nagata S; Matsushima T; Morioka T; Matsukado K; Mihara F; Sasaki T; Fukui M
    Neurosurgery; 2006 Oct; 59(4):830-6; discussion 836-7. PubMed ID: 17038947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after surgical revascularization for adult Moyamoya disease: A Southeast Asian tertiary centre experience.
    Teo CKA; Zheng Y; Lin JB; Teoh HL; Chan BPL; Sharma VK; Teo K; Nga VDW; Yeo TT
    J Clin Neurosci; 2024 Jan; 119():116-121. PubMed ID: 38006812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of moyamoya syndrome in patients with Noonan syndrome.
    Gupta M; Choudhri OA; Feroze AH; Do HM; Grant GA; Steinberg GK
    J Clin Neurosci; 2016 Jun; 28():107-11. PubMed ID: 26778511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ischemic complications following surgical treatment of moyamoya disease: risk factors and prevention].
    Lukshin VA; Shulgina AA; Usachev DY; Korshunov AE; Belousova OB; Lubnin AY
    Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(6):26-35. PubMed ID: 34951757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivy sign: a diagnostic and prognostic biomarker for pediatric moyamoya.
    Montaser AS; Lalgudi Srinivasan H; Staffa SJ; Zurakowski D; Slingerland AL; Orbach DB; Hausman-Kedem M; Roth J; Smith ER
    J Neurosurg Pediatr; 2022 Apr; 29(4):458-466. PubMed ID: 34972077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.